Prognostic value of response to preoperative chemoradiotherapy and residual tumor grades in tongue carcinoma

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 91, Issue 3, 2001, Pages 293-300

  Kirita, Tadaaki ^a,b   Shimooka, Hisashi ^a   Yamanaka, Yasutsugu ^a   Tatebayashi, Shigeru ^a   Yamamoto, Kunichika ^a   Nishimine, Masayoshi ^a   Sugimura, Masahito ^a  

^a Nara Medical University   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; PEPLEOMYCIN;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MALE; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PATHOLOGY; PREOPERATIVE CARE; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TONGUE TUMOR;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PEPLOMYCIN; PREOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TONGUE NEOPLASMS;

EID: 0035286992     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2001.112686     Document Type: Article

References (16)

1. Nyman J, Mercke C, Lindstrom J. Prognostic factors for local control and survival of cancer of the oral tongue. Acta Oncol 1993;32:667-73.
2. Overholt SM, Eicher SA, Wolf P, Weber RS. Prognostic factors affecting outcome in lower gingival carcinoma. Laryngoscope 1996;106:1335-9.
3. Gluckman JL, Pavelic ZP, Welkoborsky HJ, Mann W, Stambrook P, Gleich L, et al. Prognostic indicators for squamous cell carcinoma of the oral cavity: a clinicopathologic correlation. Laryngoscope 1997;107:1239-44.
4. Werkmeister R, Brandt B, Joos U. Clinical relevance of erbB-1 and -2 oncogenes in oral carcinomas. Oral Oncol 2000;36:100-5.
5. Smith BD, Haffty BG. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma. Radiat Oncol Investig 1997;7:125-44.
6. Verbin RS, Bouquot JE, Guggenheim J, Barnes L, Peel RL. Cancer of the oral cavity and oropharynx. In: Barnes L. ed. Surgical pathology of the head and neck, Vol 1, New York: Marcel Dekker; 1985. p. 333-401.
7. Kohama G. Mundhohlenkarzinom Diagnose und Behandlung. Tokyo: Dental Diamond; 1989. p. 244-62.
8. Kirita T, Ohgi K, Tsuyuki M, Kamikaido N, Yamamoto K, Sugimura M. Preoperative simultaneous cisplatin- or carbo-platin-based chemotherapy and radiotherapy for squamous cell carcinoma of the oral cavity. J Surg Oncol 1996;63:240-8.
9. Kirita T, Ohgi K, Shimooka H, Yamanaka Y, Tatebayashi S, Yamamoto Ku, et al. Preoperative concurrent chemoradiotherapy plus radical surgery for advanced squamous cell carcinoma of the oral cavity: an analysis of long-term results. Oral Oncol 1999;35:597-606.
10. Glicksman AS, Slotman G, Doolittle C III, Clark J, Koness J, Coachman N, et al. Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys 1994;30:1043-50.
11. Shimosato Y, Oboshi S, Baba K. Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas. Jpn J Clin Oncol 1971;1:19-35.
12. Al-Sarraf M, Pajak TF, Marcial VA, Mowry P, Cooper JS, Stetz J, et al. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. Cancer 1987;59:259-65.
13. Al-Kourainy K, Kish J, Ensley J, Tapazoglou E, Jacobs J, Weaver A, et al. Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer 1987;59:233-8.
14. Chougule PB, Suk S, Chu QD, Leone L, Nigri PT, McRae R, et al. Cisplatin as a radiation sensitizer in the treatment of advanced head and neck cancers: results of a phase II study. Cancer 1994;74:1929-32.
15. Kirita T, Okabe S, Izumo T, Sugimura M. Risk factors for the postoperative local recurrence of tongue carcinoma. J Oral Maxillofac Surg 1994;52:149-54.
16. Spiro RH, Huvos AG, Wong GY, Spiro JD, Gnecco CA, Strong EW. Predictive value of tumor thickness in squamous cell carcinoma confined to the tongue and floor of the mouth. Am J Surg 1986;152:345-50.